U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Mon Oct 21 19:46:02 UTC 2019
Edited
by admin
on Mon Oct 21 19:46:02 UTC 2019
Protein Sub Type
Sequence Type COMPLETE
Record UNII
EJC4C3UYXH
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ANDROGEN RECEPTOR
Common Name English
AR
Common Name English
DHTR
Common Name English
NR3C4
Common Name English
NUCLEAR RECEPTOR SUBFAMILY 3 GROUP C MEMBER 4
Common Name English
DIHYDROTESTOSTERONE RECEPTOR
Common Name English
Code System Code Type Description
UNIPROT
P10275
Created by admin on Mon Oct 21 19:46:02 UTC 2019 , Edited by admin on Mon Oct 21 19:46:02 UTC 2019
PRIMARY
Related Record Type Details
AGONIST -> TARGET
Fluoxymesterone is an Androgen. The mechanism of action of fluoxymesterone is as an Androgen Receptor Agonist
ANTAGONIST
IC50
AGONIST -> TARGET
Cyproterone acetate is an androgen receptor (AR) antagonist with IC50 of 7.1 nM, as well as a weak progesterone receptor agonist with weak pro-gestational and glucocorticoid activity.
ANTAGONIST
IC50
AGONIST -> TARGET
INHIBITOR -> TARGET
AGONIST -> TARGET
Cyproterone acetate is an androgen receptor (AR) antagonist with IC50 of 7.1 nM, as well as a weak progesterone receptor agonist with weak pro-gestational and glucocorticoid activity
ANTAGONIST
IC50
INHIBITOR -> TARGET
INHIBITOR -> TARGET
an androgen-receptor (AR) antagonist with IC50 of 36 nM in LNCaP cells.
ANTAGONIST
IC50
AGONIST -> TARGET
Andarine is a selective non-steroidal androgen receptor (AR) agonist with Ki of 4 nM, tissue-selective for anabolic organs. Phase 3
ANTAGONIST
IC50
AGONIST -> TARGET
AGONIST -> TARGET
AGONIST -> TARGET
Spironolactone is a potent antagonist of the androgen receptor with IC50 of 77 nM.
ANTAGONIST
IC50
INHIBITOR -> TARGET
Bicalutamide Bicalutamide is an androgen receptor (AR) antagonist with IC50 of 0.16 μM in LNCaP/AR(cs)cell line
ANTAGONIST
IC50
AGONIST -> TARGET
INHIBITOR -> TARGET
Flutamide is an antiandrogen drug, with its active metablolite binding at androgen receptor with Ki values of 55 nM, and primarily used to treat prostate cancer
ANTAGONIST
IC50
AGONIST -> TARGET
AGONIST -> TARGET
ODM-201 is a novel androgen receptor (AR) antagonist that blocks AR nuclear translocation with Ki of 11 nM. Phase 3.
ANTAGONIST
IC50
AGONIST -> TARGET
MK-2866 (GTx-024) is a selective androgen receptor modulator (SARM) with Ki of 3.8 nM, and is tissue-selective for anabolic organs. Phase 3.
ANTAGONIST
IC50
INHIBITOR -> TARGET
ARN-509 is a selective and competitive androgen receptor inhibitor with IC50 of 16 nM in a cell-free assay, useful for prostate cancer treatment. Phase 3
ANTAGONIST
IC50
AGONIST -> TARGET
AGONIST -> TARGET
Dehydroepiandrosterone is an important endogenous steroid hormone, which is an androgen receptor antagonist and an estrogen receptor agonist
ANTAGONIST
IC50
AGONIST -> TARGET
Galeterone is a selective CYP17 inhibitor and androgen receptor (AR) antagonist with IC50 of 300 nM and 384 nM, respectively, and is a potent inhibitor of human prostate tumor growth. Phase 2.
ANTAGONIST
IC50
INHIBITOR -> TARGET
INHIBITOR OF EXPRESSION->TARGET
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT CHEMICAL